| Abigail R Laplant I, APNP | |
|
2820 Roosevelt Rd, Marinette, WI 54143-3834 | |
| (715) 735-5225 | |
| (715) 735-5388 |
| Full Name | Abigail R Laplant I |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 2820 Roosevelt Rd, Marinette, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447855002 | NPI | - | NPPES |
| F06202866 | Other | AMERICAN ACADEMY OF NURSE PRACTITIONERS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 10345-33 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oconto Hospital And Medical Center Inc | 2163461781 | 201 |
News Archive
The New York Times reports that conservatives are hungry for a real debate beyond the rhetoric at these events: "Far from embracing the attacks, many leading conservative health care policy experts said in recent interviews that the dynamic was precluding a more robust real-world debate while making it nearly impossible for them to inject their studied, free-market solutions into the discussion.
A new study funded by U.S. National Institute for Occupational Safety and Health reports that foreign-born workers reported a lower rate of non-fatal work-related injuries than U.S.-born workers, based on data collected from the National Health Interview Survey from 1997 to 2005.
Jellyfish Health, the company reducing wait times and enhancing the patient experience, today launched Jellyfish Connect, a software-based platform that gives patients the convenience of finding, scheduling and waiting for a doctor using their mobile device.
Small and innovative pharmaceutical companies, with products in early stages of development, presented some of their novel approaches and antimicrobial therapies under development during a dedicated session at the annual congress (ECCMID) of the European Society of Clinical Microbiology and Infectious Diseases(ESCMID) in Amsterdam.
Onconova Therapeutics, Inc., and SymBio Pharmaceuticals Limited announced today that they will collaborate to develop and commercialize rigosertib in Japan and Korea. Onconova is conducting late-stage clinical trials with rigosertib (ON 01910.Na) in the U.S., Europe and India for the treatment of Myelodysplastic Syndromes (MDS) and solid tumors.
› Verified 1 days ago
| Entity Name | Bellin Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609838473 PECOS PAC ID: 8820900749 Enrollment ID: O20031121000089 |
News Archive
The New York Times reports that conservatives are hungry for a real debate beyond the rhetoric at these events: "Far from embracing the attacks, many leading conservative health care policy experts said in recent interviews that the dynamic was precluding a more robust real-world debate while making it nearly impossible for them to inject their studied, free-market solutions into the discussion.
A new study funded by U.S. National Institute for Occupational Safety and Health reports that foreign-born workers reported a lower rate of non-fatal work-related injuries than U.S.-born workers, based on data collected from the National Health Interview Survey from 1997 to 2005.
Jellyfish Health, the company reducing wait times and enhancing the patient experience, today launched Jellyfish Connect, a software-based platform that gives patients the convenience of finding, scheduling and waiting for a doctor using their mobile device.
Small and innovative pharmaceutical companies, with products in early stages of development, presented some of their novel approaches and antimicrobial therapies under development during a dedicated session at the annual congress (ECCMID) of the European Society of Clinical Microbiology and Infectious Diseases(ESCMID) in Amsterdam.
Onconova Therapeutics, Inc., and SymBio Pharmaceuticals Limited announced today that they will collaborate to develop and commercialize rigosertib in Japan and Korea. Onconova is conducting late-stage clinical trials with rigosertib (ON 01910.Na) in the U.S., Europe and India for the treatment of Myelodysplastic Syndromes (MDS) and solid tumors.
› Verified 1 days ago
| Entity Name | Oconto Hospital & Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356373302 PECOS PAC ID: 2163461781 Enrollment ID: O20050713000836 |
News Archive
The New York Times reports that conservatives are hungry for a real debate beyond the rhetoric at these events: "Far from embracing the attacks, many leading conservative health care policy experts said in recent interviews that the dynamic was precluding a more robust real-world debate while making it nearly impossible for them to inject their studied, free-market solutions into the discussion.
A new study funded by U.S. National Institute for Occupational Safety and Health reports that foreign-born workers reported a lower rate of non-fatal work-related injuries than U.S.-born workers, based on data collected from the National Health Interview Survey from 1997 to 2005.
Jellyfish Health, the company reducing wait times and enhancing the patient experience, today launched Jellyfish Connect, a software-based platform that gives patients the convenience of finding, scheduling and waiting for a doctor using their mobile device.
Small and innovative pharmaceutical companies, with products in early stages of development, presented some of their novel approaches and antimicrobial therapies under development during a dedicated session at the annual congress (ECCMID) of the European Society of Clinical Microbiology and Infectious Diseases(ESCMID) in Amsterdam.
Onconova Therapeutics, Inc., and SymBio Pharmaceuticals Limited announced today that they will collaborate to develop and commercialize rigosertib in Japan and Korea. Onconova is conducting late-stage clinical trials with rigosertib (ON 01910.Na) in the U.S., Europe and India for the treatment of Myelodysplastic Syndromes (MDS) and solid tumors.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abigail R Laplant I, APNP Po Box 1866, Green Bay, WI 54305-1866 Ph: (920) 445-7222 | Abigail R Laplant I, APNP 2820 Roosevelt Rd, Marinette, WI 54143-3834 Ph: (715) 735-5225 |
News Archive
The New York Times reports that conservatives are hungry for a real debate beyond the rhetoric at these events: "Far from embracing the attacks, many leading conservative health care policy experts said in recent interviews that the dynamic was precluding a more robust real-world debate while making it nearly impossible for them to inject their studied, free-market solutions into the discussion.
A new study funded by U.S. National Institute for Occupational Safety and Health reports that foreign-born workers reported a lower rate of non-fatal work-related injuries than U.S.-born workers, based on data collected from the National Health Interview Survey from 1997 to 2005.
Jellyfish Health, the company reducing wait times and enhancing the patient experience, today launched Jellyfish Connect, a software-based platform that gives patients the convenience of finding, scheduling and waiting for a doctor using their mobile device.
Small and innovative pharmaceutical companies, with products in early stages of development, presented some of their novel approaches and antimicrobial therapies under development during a dedicated session at the annual congress (ECCMID) of the European Society of Clinical Microbiology and Infectious Diseases(ESCMID) in Amsterdam.
Onconova Therapeutics, Inc., and SymBio Pharmaceuticals Limited announced today that they will collaborate to develop and commercialize rigosertib in Japan and Korea. Onconova is conducting late-stage clinical trials with rigosertib (ON 01910.Na) in the U.S., Europe and India for the treatment of Myelodysplastic Syndromes (MDS) and solid tumors.
› Verified 1 days ago
Kathy Ann Brattain, APNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3200 Shore Dr, Suite 4, Marinette, WI 54143 Phone: 715-732-8610 Fax: 715-732-8650 | |
Megan D Sekora, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3003 University Dr, Marinette, WI 54143 Phone: 414-389-2338 | |
Lynda J. Bahde, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2935 Shore Dr, Marinette, WI 54143 Phone: 715-732-9193 Fax: 715-732-9196 | |
Sharon L Fellion, RNC WHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3123 Shore Dr Ste 201, Womans Specialty Care, Marinette, WI 54143 Phone: 715-735-6263 Fax: 715-735-5692 | |
Katie J Rettler, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2820 Roosevelt Rd, Marinette, WI 54143 Phone: 715-735-5225 Fax: 715-735-5388 | |
Erika Marie Goddard, APNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3003 University Dr, Marinette, WI 54143 Phone: 715-735-4200 | |
Christine M Walters, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3003 University Dr, Marinette, WI 54143 Phone: 715-735-4200 |